Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blajchman, M. A.
Right arrow Articles by Singal, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blajchman, M. A.
Right arrow Articles by Singal, D. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Allogeneic blood transfusion-induced enhancement of tumor growth: two animal models showing amelioration by leukodepletion and passive transfer using spleen cells [see comments]

MA Blajchman, L Bardossy, R Carmen, A Sastry and DP Singal

Department of Pathology, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.

Allogeneic blood transfusions have been reported to induce immunomodulation in recipients of blood products. While the mechanism(s) of this immunomodulatory effect is unknown, it has been suggested that this effect of allogeneic blood transfusions could adversely affect patients with a malignant disorder. These concerns have been supported by a number of nonrandomized, mainly retrospective, clinical studies which indicate that allogeneic blood transfusions can adversely affect prognosis following the surgical treatment of oncology patients. Recently, we have shown that allogeneic blood transfusions enhance primary tumor growth and increase metastatic pulmonary nodule formation in inbred mice. The tumor growth-promoting activity of allogeneic blood transfusions was studied also using outbred rabbits. In this present study, we demonstrate that the tumor growth-promoting effect of allogeneic blood transfusions is mediated by donor leukocytes and that this effect can be abolished by their removal before transfusion. We show also that the allogeneic blood transfusion tumor growth-promoting effect can be passively transferred to naive animals (both mice and rabbits) using spleen cells from allogeneically transfused animals. In these experiments, numbers of metastatic pulmonary nodules were significantly increased in both mice and rabbits that had received spleen cells from allogeneically transfused animals compared with those that had received spleen cells from syngeneically transfused animals, or from animals that had been transfused with leukodepleted allogeneic blood.

Volume 81, Issue 7, pp. 1880-1882, 04/01/1993
Copyright © 1993 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
J. Kanter, S. Y. Khan, M. Kelher, L. Gore, and C. C. Silliman
Oncogenic and Angiogenic Growth Factors Accumulate during Routine Storage of Apheresis Platelet Concentrates
Clin. Cancer Res., June 15, 2008; 14(12): 3942 - 3947.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. Weitz, M. D'Angelica, M. Gonen, D. Klimstra, D. G. Coit, M. F. Brennan, and M. S. Karpeh
Interaction of Splenectomy and Perioperative Blood Transfusions on Prognosis of Patients With Proximal Gastric and Gastroesophageal Junction Cancer
J. Clin. Oncol., December 15, 2003; 21(24): 4597 - 4603.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
A. C. Collier, L. A. Kalish, M. P. Busch, T. Gernsheimer, S. F. Assmann, T. A. Lane, D. M. Asmuth, M. M. Lederman, E. L. Murphy, P. Kumar, et al.
Leukocyte-Reduced Red Blood Cell Transfusions in Patients With Anemia and Human Immunodeficiency Virus Infection: The Viral Activation Transfusion Study: A Randomized Controlled Trial
JAMA, March 28, 2001; 285(12): 1592 - 1601.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. C. Vamvakas and M. A. Blajchman
Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?
Blood, March 1, 2001; 97(5): 1180 - 1195.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. D. Sharma, G. Sreeram, T. Erb, H. P. Grocott, and T. F. Slaughter
Leukocyte-Reduced Blood Transfusions: Perioperative Indications, Adverse Effects, and Cost Analysis
Anesth. Analg., June 1, 2000; 90(6): 1315 - 1323.
[Full Text] [PDF]


Home page
Arch SurgHome page
R. L. Quigley
The Effect of Leukocytes on Adhesion Molecules: An Explanation of Blood Transfusion Enhancement of Tumor Growth
Arch Surg, April 1, 1996; 131(4): 438 - 441.
[Abstract] [PDF]


Home page
PerfusionHome page
S. Hart and J. Roe
Leucocyte depleting filters and cardiothoracic surgery
Perfusion, November 1, 1993; 8(6): 477 - 482.
[Abstract] [PDF]


Home page
NEJMHome page
W. B. Ross, N. Blumberg, J. M. Heal, O. R.C. Busch, R. L. Marquet, W. C.J. Hop, and J. Jeekel
Blood Transfusions and Prognosis in Colorectal Cancer
N. Engl. J. Med., October 28, 1993; 329(18): 1354 - 1356.
[Full Text]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1993 by American Society of Hematology         Online ISSN: 1528-0020